Boston Scientific Corp. (NYSE: BSX) reported lower fourth quarter revenue and earnings of 4 cents per share compared with 7 cents per share in the year ago period but the medical device maker announced the elimination of up to 1,000 jobs in order to save $100 million to $115 million per year. The stock price rose 36 cents to $7.22.